Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAR trial: acetazolamide for cystoid macular edema in inherited retinal dystrophies
2022-000237-17Phase 3Completed
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of acetazolamide in cystoid macular edema (CME) (2 arms). Primary endpoints: Effective dosage determination, Treatment outcome on cystoid macular edema and 2 more. Started Jun 2022; status: completed.
02
Drugs
acetazolamide
03
Conditions
cystoid macular edema (CME)
Beyond the preview
Go deeper on 2022-000237-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-000237-17.